DiagnaMed Holdings Corp. (CSE: DMED) (OTCQB: DGNMF) ("DiagnaMed", "DMED", or the "Company"), a leading provider of ...
StudyFinds on MSN15h
Breakthrough blood test could transform ALS diagnosis, careFind out about the new ALS blood test that offers accurate diagnosis and could replace traditional invasive testing methods.
Biogen Canada Inc. announced today that Health Canada has issued marketing authorization with conditions (Notice of Compliance ...
DiagnaMed Holdings Corp. (CSE: DMED) (OTCQB: DGNMF) ("DiagnaMed", "DMED", or the "Company"), a leading provider of cutting-edge technology solutions ...
News Medical on MSN18h
Stress granules as potential biomarkers for neurodegenerative diseasesStress granules (SGs) are transient organelles that form when cells experience stress, serving as critical hubs for RNA metabolism and cellular survival.
Donald Trump’s health has sparked debate after a video showed him limping during a golf outing. While some speculate about ...
Revive Therapeutics (RVVTF) has entered into a non-binding letter of intent, dated February 28, 2025, to acquire the full rights to DiagnaMed ...
HC Wainwright restated their buy rating on shares of Voyager Therapeutics (NASDAQ:VYGR – Free Report) in a report released on ...
Equities researchers at Leerink Partnrs issued their Q1 2025 EPS estimates for argenx in a research report issued to clients ...
JRMC undergraduate students as well as AUCTV and graduate students from the Kamal Adham Center received several awards at media and film festivals in Egypt.
Multiple system atrophy (MSA) is not exactly a household word – a situation that Alterity Therapeutics is seeking to change.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback